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Abstract
IMPORTANCE Identifying plasma biomarkers associated with the amount of time an athlete may
need before they return to sport (RTS) following a sport-related concussion (SRC) is important
because it may help to improve the health and safety of athletes.
OBJECTIVE To examine whether plasma biomarkers can differentiate collegiate athletes who RTS
in less than 14 days or 14 days or more following SRC.
DESIGN, SETTING, AND PARTICIPANTS This multicenter prospective diagnostic study, conducted
by the National Collegiate Athletics Association–Department of Defense Concussion Assessment,
Research, and Education Consortium, included 127 male and female athletes who had sustained an
SRC while enrolled at 6 Concussion Assessment, Research, and Education Consortium Advanced
Research Core sites as well as 2 partial–Advanced Research Core military service academies. Data
were collected between February 2015 and May 2018. Athletes with SRC completed clinical testing
and blood collection at preseason (baseline), postinjury (0-21 hours), 24 to 48 hours postinjury, time
of symptom resolution, and 7 days after unrestricted RTS.
MAIN OUTCOMES AND MEASURES A total of 3 plasma biomarkers (ie, total tau protein, glial
fibrillary acidic protein [GFAP], and neurofilament light chain protein [Nf-L]) were measured using an
ultrasensitive single molecule array technology and were included in the final analysis. RTS was
examined between athletes who took less than 14 days vs those who took 14 days or more to RTS
following SRC. Linear mixed models were used to identify significant interactions between period by
RTS group. Area under the receiver operating characteristic curve analyses were conducted to
examine whether these plasma biomarkers could discriminate between RTS groups.
RESULTS The 127 participants had a mean (SD) age of 18.9 (1.3) years, and 97 (76.4%) were men; 65
(51.2%) took less than 14 days to RTS, and 62 (48.8%) took 14 days or more to RTS. Linear mixed
models identified significant associations for both mean (SE) plasma total tau (24-48 hours
postinjury, <14 days RTS vs 14 days RTS: −0.65 [0.12] pg/mL vs −0.14 [0.14] pg/mL; P = .008) and
GFAP (postinjury, 14 days RTS vs 14 days RTS: 4.72 [0.12] pg/mL vs 4.39 [0.11] pg/mL; P = .04). Total
tau at the time of symptom resolution had acceptable discrimination power (area under the receiver
operating characteristic curve, 0.75; 95% CI, 0.63-0.86; P < .001). We also examined a combined
plasma biomarker panel that incorporated Nf-L, GFAP, and total tau at each period to discriminate
RTS groups. Although the analyses did reach significance at each time period when combined, results




Question Are plasma biomarkers
associated with a return-to-sport period
of less than 14 days vs 14 days or more
in male and female collegiate athletes
following a sport-related concussion?
Findings This diagnostic study, which
included 127 collegiate athletes who had
sustained a sports-related concussion,
found that higher total tau
concentrations 24 to 48 hours after
injury and at the time of symptom
resolution as well as lower glial fibrillary
acidic protein levels acutely postinjury
were associated with return-to-sport
decisions.
Meaning In this study, total tau and glial
fibrillary acidic protein levels were
associated with return to sport in male
and female collegiate athletes following
a sports-related concussion.
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Abstract (continued)
CONCLUSIONS AND RELEVANCE The findings of this study suggest that measures of total tau and
GFAP may identify athletes who will require more time to RTS. However, further research is needed
to improve our ability to determine recovery following an SRC.
JAMA Network Open. 2020;3(8):e2013191. doi:10.1001/jamanetworkopen.2020.13191
Introduction
Sport-related concussion (SRC) is prevalent across multiple sports and can be challenging to manage
clinically.1 Return-to-sport (RTS) decisions are essential for ensuring safety, given that the risk of
subsequent concussion is increased if an athlete returns to play prior to full clinical and
neurobiological recovery.2,3 Furthermore, early RTS may have negative consequences on long-term
neurologic health. Findings suggest that athletes may have increased vulnerability to subsequent
concussions, with subsequent increased risk of chronic symptoms, functional impairments, and
possibly neurodegenerative disease.2,4,5 Peripheral blood-based biomarkers present an opportunity
to objectively measure proteins that may be indicative of injury severity alongside neuronal recovery.
Thus, following diagnosis of SRC, blood biomarkers may allow us to identify those athletes at risk of
prolonged recovery, with the aim of ensuring athletes are not only asymptomatic but also show signs
of neuronal recovery when returning to sport.
SRC has a complex pathophysiology comprising multiple neurobiological effects. Candidate
biomarkers of these pathophysiologic mechanisms include total tau and neurofilament light chain
protein (Nf-L), microtubule-associated proteins from neurons, and glial fibrillary acidic protein
(GFAP), released from astrocytes. Recent research demonstrated that elevated total tau levels in
blood 6 hours postconcussion were associated with prolonged RTS in collegiate athletes.6 These
findings are consistent with data from professional ice hockey players, which found that elevations
in total tau at 1 hour postinjury and Nf-L at 1, 12, 36, and 144 hours postinjury were associated with
longer RTS time (ie, >10 days).7,8 However, not all studies support these findings, with a 2018 study
reporting no significant associations between Nf-L or total tau with RTS.9 Furthermore, research
that investigates other classic markers of mild traumatic brain injury (mTBI), such as GFAP and
ubiquitin C-terminal hydrolase-L1 (UCH-L1), which have been linked to persistent symptoms and
injury severity,10 is lacking in collegiate athlete populations following SRC.
The aim of this study was to assess the utility of plasma biomarkers, including total tau, Nf-L,
GFAP, and UCHL-1, in discriminating RTS decisions among collegiate athletes who sustained an SRC.
Current guidelines from the National Collegiate Athletics Association (NCAA) indicate that collegiate
athletes will typically be asymptomatic within 14 days after an SRC.11 These statistics also aligned with
the median (interquartile range [IQR]) RTS time for the Concussion Assessment, Research, and
Education (CARE) Consortium sample (whole sample, 12.9 [8.7-20.7] days; men, 12.2 [8.3-19.7] days;
women, 13.7 [9.1-23.6] days).12 Thus, 14 days was the cut point used to determine whether blood-
based biomarkers could differentiate athletes with SRC who were able to RTS in less than 14 days
compared with those who took 14 days or more to RTS.
Methods
This was a multicenter, prospective diagnostic study led by the Advanced Research Core (ARC) of the
NCAA–Department of Defense CARE Consortium. This study was approved by the Medical College
of Wisconsin institutional review board and the Human Research Protection Office at the US Army
Medical Research and Material Command. Written informed consent was obtained from all
participants. The study followed the Standards for Reporting of Diagnostic Accuracy (STARD) reporting
guideline.
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Participants
Of the CARE ARC and partial-ARC databases, 308 participants were identified as having sustained an
SRC at some point during the study. Of these participants, 139 had provided a blood sample at
postinjury. Of those, 12 (8.6%) had missing RTS information. Thus, the final sample included 127
participants who had sustained an SRC with both RTS information and a blood sample provided at
postinjury.
Procedures
The CARE Consortium ARC has been detailed elsewhere.13 Briefly, the protocol involves preseason
baseline clinical testing and blood biospecimen collection in male and female athletes competing in
contact sports, including football, soccer, lacrosse, ice hockey, and rugby, at 6 participating US
universities, including 2 military service academies. Concussion (or mTBI) was defined according to
the consensus definition from the Department of Defense evidence-based guidelines and could
include observed or documented alterations of consciousness and/or mental state (within 24 hours),
less than 30 minutes of loss of consciousness (LOC), and/or posttraumatic amnesia lasting for as long
as 1 day.14 Alongside the preseason baseline testing, the CARE postinjury protocol included follow-up
clinical testing and blood collection in athletes with concussion at 5 periods: 0 to 21 hours postinjury,
24 to 48 hours postinjury, time of symptom resolution (ie, athletes were asked to return for testing
when they had been cleared to begin the RTS progression),13 7 days after unrestricted RTS, and 6
months postinjury. Because the aim of this study was to investigate change in acute plasma
biomarker concentrations following injury, the 6-month postinjury period was excluded from
analyses.
RTS
Current guidelines from the NCAA indicate that collegiate athletes will typically be asymptomatic
within 2 weeks following an SRC.11 In line with these guidelines, the median (IQR) RTS time for the
entire CARE sample was 12.9 (8.7-20.7) days.12 Furthermore, this point closely corresponded with the
individual being asymptomatic, which was required for an RTS decision to be made. As such, we used
a medium-split model to determine whether there were observable differences in peripheral blood
biomarkers that could differentiate athletes with SRC who were able to RTS in less than 14 days
compared with those who took more than 14 days to RTS.
Blood Collection
Nonfasting blood samples were collected by venipuncture at preseason baseline and at all
subsequent postinjury periods that the athletes attended. A 10-mL red-top tube for plasma was
collected at each period. Tubes were centrifuged within 30 minutes of collection for 15 minutes at
1500 relative centrifugal force and then aliquoted. The cryovials were stored upright in a −80 °C
freezer until shipped on dry ice to the CARE Consortium biorepository at Indiana University School of
Medicine for long-term storage.
Biomarker Analysis
Single molecular array technology (SIMOA, Quanterix Corp), located at the National Institutes of
Health, was used to measure the level of all biomarkers. The use of SIMOA for protein detection
maximizes sensitivity, with detection ability between 100 to 1000 times that of enzyme-linked
immunosorbent assay methods.15 Multiplex technology was used to simultaneously quantify
UCH-L1, total tau, Nf-L, and GFAP. Assays were batched to minimize variability, with each batch run
using published standard operating procedures to ensure reliability. Groups were distributed
randomly across plates, and longitudinal samples from the same individual were run on the same
plate to reduce potential batch effects. All samples were analyzed in duplicate. In the rare instances
in which coefficients of variance (CV) exceeded 20%, samples were rerun. If either intra-assay or
interassay CVs were greater than 20% for either measure, data were not used. The mean CVs for
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each plasma protein were the following for data included in the analyses: total tau, 7.92%; Nf-L,
4.59%; and GFAP, 3.07%. The limits of detection are as follows: total tau, 0.0146 pg/mL; Nf-L, 0.038
pg/mL; GFAP, 0.211 pg/mL; and UCH-L1, 1.05 pg/mL. For UCH-L1, approximately 42% of samples
were either below the detection limit or had CVs above 20%; therefore, UCH-L1 was not reported.
Statistical Analysis
Statistical analyses were performed using SPSS statistical software version 25.0 (IBM Corp).
Statistically significant results were declared at the nominal significance level α = .05. Time from
injury to blood draw was calculated to ensure that the draw occurred within the prescribed
protocol window.
The postinjury period had the most missing data owing to late reporting or difficulties in data
collection (eg, away games). However, additional analysis of those with and without missing
biomarker data at the postinjury period found that the groups did not significantly differ on any
demographic variables (eTable in the Supplement).
Group comparisons of demographic characteristics and clinical outcomes were evaluated using
independent-sample t tests for continuous variables and Fisher exact tests for categorical variables.
Biomarker levels were natural log-transformed owing to the skewness of their distributions. Linear
mixed models were used to evaluate changes in biomarker levels within athletes over time as a
function of RTS group, with visit period modeled as a repeated factor (ie, postinjury, 24-48 hours
postinjury, time of symptom resolution, and 7 days after unrestricted RTS), RTS group (ie, <14 days
and 14 days), the group × period interaction, and participant as random factor. All hypotheses were
2-sided, with Bonferroni adjustments applied to all post hoc pairwise comparisons.
Receiver operating characteristic curves and area under the curve (AUC) with 95% CIs were
used to quantify the ability of significant biomarkers identified to discriminate between athletes with
less than 14 days RTS and those with 14 days or more before RTS. Finally, we wanted to examine
whether a combination of biomarkers at each period could discriminate RTS duration. Therefore, we
combined all 3 plasma biomarker concentrations at each period using binomial logistic
regression models.
Results
Table 1 summarizes the sample characteristics for the athletes with RTS less than 14 days postinjury
and those with RTS 14 days or later. Participants in this study were aged 17 to 23 years (mean [SD]
age, 18.9 [1.3] years); most were men (97 [76.4%]) and White individuals (82 [64.6%]). Of the 127
athletes, the median split in RTS was at 14 days postinjury. That is, 65 (51.1%) had RTS less than 14
days and 62 (48.8%) had RTS of 14 days or more. The groups did not differ on any of the
demographic variables of age, sex, race, anthropometric data, or number of prior concussions. Most
athletes had no prior concussions (71 [55.9%]). The group that took less than 14 days before RTS had
significantly higher incidence of LOC compared with the group that took 14 days or more before RTS
(7 [10.8%] vs 0; P = .01) and a longer mean (SD) time participating in sport (11.3 [4.4] years vs 8.8
[3.4] years; P = .004). Furthermore, baseline concentrations of natural log-transformed total tau,
GFAP, and NF-L levels did not significantly differ between the groups. Table 1 presents sample
characteristics for the 2 RTS groups.
RTS Biomarkers
Linear mixed models identified significant associations for both mean (SE) plasma total tau (24-48
hours postinjury, <14 days RTS vs 14 days RTS: −0.65 [0.12] pg/mL vs −0.14 [0.14] pg/mL; P = .008)
and GFAP (postinjury, 14 days RTS vs 14 days RTS: 4.72 [0.12] pg/mL vs 4.39 [0.11] pg/mL; P = .04).
For total tau, there was a significant interaction between period and RTS group (F2.4, 128.2 = 3.66;
P = .02; np
2 = 0.065). Bonferroni-adjusted pairwise post hoc comparisons revealed that at both 24
to 48 hours postinjury and at the time of symptom resolution, the group that took 14 days or more to
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RTS had higher total tau concentrations than the group that took less than 14 days to RTS (Table 2).
For GFAP, there was a significant interaction between period and RTS groups (F1.5, 117.8 = 3.48;
P = .04; np
2 = 0.043). Pairwise post hoc comparisons indicated that the group that took 14 days or
more to RTS had significantly lower concentrations of GFAP than the group that took less than 14
days at the postinjury period (Table 2). There was also a significant interaction between period and
RTS groups (F1.9, 144.0 = 3.34; P = .04; np
2 = 0.042) for Nf-L. However, pairwise post hoc comparisons
revealed no significant associations after Bonferroni adjustment (Table 2).
We then conducted receiver operating characteristic curve analysis to examine whether the
biomarkers and periods identified as significant could discriminate between athletes with 14 days or
more before RTS from those with less than 14 days before RTS. The analysis indicated that total tau
at the period of symptom resolution had acceptable16 discrimination power (AUC, 0.75; 95% CI,
0.63-0.86; P < .001) (Table 3).
Table 1. Demographic and Clinical Characteristics of Athletes in Each RTS Group
Characteristic
No. (%) by RTS group
P value<14-d (n = 65) ≥14-d (n = 62)
Age, mean (SD), y 19.1 (1.4) 18.7 (1.2) .19
Men 51 (78.5) 46 (74.2) .57
Height, mean (SD), cm 179.6 (9.7) 178.6 (12.2) .57
Weight, mean (SD), kg 84.3 (19.2) 82.9 (21.5) .71
Duration of sport participation, mean (SD), y 11.31 (4.4) 8.8 (3.4) .004
Race
White 43 (66.2) 39 (62.9)
.55
African American 12 (18.5) 12 (19.4)
Asian 3 (4.6) 5 (8.1)
Hawaiian or Pacific Islander 0 2 (3.2)
Multiple 6 (9.2) 4 (6.5)
Unknown or not reported 1 (1.5) 0
Ethnicity
Non-Hispanic 54 (83.1) 55 (88.7)
.63Hispanic 4 (6.2) 2 (3.2)
Unknown or not reported 7 (10.8) 5 (8.1)
With ADHD 6 (9.2) 1 (1.6) .12a
Sport
Football 24 (43.6) 22 (53.7)
.11
Ice hockey 4 (7.3) 0
Lacrosse 3 (5.5) 3 (7.3)
Rugby 5 (9.1) 3 (7.3)
Soccer 14 (25.5) 5 (12.2)
Other 5 (9.1) 8 (17.0)
PTA 12 (18.5) 12 (19.4) .90
LOC, yes 7 (10.8) 0 .01a
No. of prior concussions
0 32 (50.0) 39 (63.9)
.13
1 23 (35.9) 20 (32.8)
2 7 (10.9) 2 (3.3)
≥3 2 (3.1) 0
Time to symptom resolution, median (IQR), d 4.0 (3.4) 11.9 (6.9) <.001b
Baseline biomarker concentrations, mean (SD), LN pg/mL
Total tau −0.2 (0.6) −0.2 (0.8) .85
GFAP 4.1 (0.4) 4.0 (0.4) .43
Nf-L 1.8 (0.5) 1.6 (0.5) .06
Abbreviations: ADHD, attention-deficit/hyperactivity
disorder; GFAP, glial fibrillary acidic protein; IQR,
interquartile range; LN, natural log-transformation;
LOC, loss of consciousness; Nf-L, neurofilament light
chain protein; PTA, posttraumatic amnesia; RTS, return
to sport.
a Result from 2-tailed Fisher exact test.
b Result from nonparametric Mann-Whitney U test.
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We also examined how well a combined biomarker panel, which incorporated Nf-L, GFAP, and
total tau at each period, discriminated between athletes with 14 days or more before RTS vs those
with less than 14 days before RTS. At postinjury, no single biomarker significantly discriminated
between the groups when examined individually. However, when the biomarkers were combined,
they reached significance, but were poor16 at distinguishing the groups (AUC, 0.63; 95% CI,
0.53-0.73; P = .02). At 24 to 48 hours postinjury, total tau individually was significant but had a low
AUC (AUC, 0.65; 95% CI, 0.53-0.78; P = .02). The combination of all 3 plasma biomarkers added little
to the prognostic ability of total tau individually at the 24 to 48 hours postinjury period (AUC, 0.67;
95% CI, 0.55-0.79; P = .01). A similar pattern was observed at the period of symptom resolution, with
total tau once again being significant and able to discriminate between the RTS groups. The
combination of biomarkers was also significant but added little to the prognostic ability of the model
(AUC, 0.67; 95% CI, 0.57-0.77; P = .002).
Discussion
Clinical management of SRC is challenging and further complicated by the lack of objective
prognostic indicators to help inform clinical decisions, particularly for athletes who may be at risk of
prolonged recovery. In this study, we examined the utility of blood biomarkers that may be
associated with RTS decisions in 127 NCAA male and female student-athletes who sustained an SRC
Table 2. Pairwise Post Hoc Comparisons of Biomarker Concentrations Between Athletes Who Had Sustained
a Sport-Related Concussion, by RTS Groupa
Biomarker
Level, mean (SE),
by RTS group, pg/mL
P value Mean difference (95% CI)<14 d ≥14 d
Total tau
Participants, No. 31 24 NA NA
Postinjury −0.06 (0.13) 0.24 (0.14) .12 −0.29 (−0.68 to 0.08)
24-48 h postinjury −0.65 (0.12) −0.14 (0.14) .008 −0.51 (−0.88 to −0.14)
Time of symptom resolution −0.54 (0.12) 0.17 (0.14) <.001 −0.71 (−1.09 to −0.34)
7 d after unrestricted RTS −0.30 (0.11) −0.13 (0.12) .31 −0.17 (−0.50 to 0.16)
GFAP
Participants, No. 37 42 NA NA
Postinjury 4.72 (0.12) 4.39 (0.11) .04 0.33 (0.01 to 0.65)
24-48 h postinjury 4.37 (0.09) 4.28 (0.08) .45 0.09 (−0.15 to 0.32)
Time of symptom resolution 4.26 (0.06) 4.21 (0.06) .59 0.04 (−0.12 to 0.21)
7 d after unrestricted RTS 4.27 (0.07) 4.16 (0.06) .23 0.11 (−0.07 to 0.29)
Nf-L
Participants, No. 36 42 NA NA
Postinjury 1.97 (0.07) 1.92 (0.07) .59 0.05 (−0.14 to 0.25)
24-48 h postinjury 1.89 (0.07) 1.87 (0.06) .81 0.02 (−0.16 to 0.21)
Time of symptom resolution 1.98 (0.08) 1.83 (0.07) .17 0.15 (−0.07 to 0.37)
7 d after unrestricted RTS 2.05 (0.09) 1.85 (0.08) .09 0.20 (−0.03 to 0.44)
Abbreviations: GFAP, glial fibrillary acidic protein; NA,
not applicable; Nf-L, neurofilament light chain protein;
RTS, return to sport.
a All variables have been natural log–transformed and
the P values and 95% CIs of the difference have been
adjusted for multiple comparisons using Bonferroni
adjustment.
Table 3. Receiver Operating Characteristic Curve Results
Variablea AUC (SE) [95% CI] P value Cut point Sensitivity Specificity PPV NPV
Tau
24-48 h postinjury 0.66 (0.06) [0.53-0.78] .02 −0.72 0.82 0.49 0.65 0.72
Time of symptom resolution 0.75 (0.06) [0.63-0.86] <.001 −0.41 0.79 0.51 0.63 0.68
GFAP, postinjury 0.40 (0.07) [0.27-0.54] .15 4.26 0.66 0.63 0.53 0.51
Abbreviations: AUC, area under the receiver operating characteristic curve; GFAP, glial
fibrillary acidic protein; NPV, negative predictive value; PPV, positive predictive value.
a All variables have been natural log–transformed.
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during sport participation. We found that athletes with less than 14 days before RTS had significantly
higher total tau at the 24 to 48 hour period and at time of symptom resolution as well as significantly
lower GFAP postinjury. Total tau was fair at discriminating those with 14 days or more before RTS vs
those with less than 14 days before RTS, especially at the time of symptom resolution. Contrary to
prior studies,7,8 Nf-L was not significantly associated with RTS decisions.
Our results indicate that athletes with 14 days or more before RTS had higher total tau at the 24
to 48 hour period, which remained elevated even when players reported being clinically
asymptomatic. This result is consistent with prior studies, which have found that higher
concentrations of total tau are associated with a longer RTS time after SRC in collegiate and
professional athletes.6,8 While the 2 RTS groups in the current study did not differ significantly on the
number of prior concussions sustained, more research is needed to identify whether there are any
long-term effects of these short-term spikes in total tau that might alter the regulation mechanisms
of tau; eg, the glymphatic system17 or subsequent vulnerability to dysregulation of tau and
hyperphosphorylation.18,19
In contrast to the tau findings, levels of GFAP at the postinjury period were lower in athletes
with SRC who took 14 days or more before RTS compared with those who took less than 14 days
before RTS. These results are counterintuitive, given that they are in contrast with prior studies in
civilian patients with mTBI. A possible explanation for the difference in our findings may be that
civilian mTBI studies often include patients with a more severe gradient of injury, even within the
mild classification, such as patients with evidence of structural brain injury on head computed
tomography. For example, higher GFAP levels acutely following an mTBI are associated with having
lesions detected by both computed tomography and magnetic resonance imaging20 and by
identifying athletes with an SRC compared with controls with no injuries.21 Indeed, our group has
previously reported that higher GFAP concentrations were associated with SRCs with LOC.22
Therefore, these results may actually support the association, given that the group with less than 14
days before RTS did report significantly higher incidence of LOC (Table 1). Alternatively, it may be
that any increase in GFAP following the injury, potentially after the 48-hour sampling frame, may
have been missed due to the timing of the blood samples.23,24 Whatever the cause of this finding, it
is evident that research to better understand the release kinetics and significance of perturbations to
the normally expected temporal profile of GFAP is warranted, particularly if this marker is to be
considered as a guide to treatment options related to SRC.
Nf-L levels did not discriminate RTS duration in this cohort. Elevated levels of Nf-L are believed
to reflect axonal damage due to injury or degeneration, which is a possible determinant of outcomes
following concussions.25-27 Our findings expand on a previous study9 that reported no significant
difference in plasma Nf-L levels at 6 and 14 days post-SRC relative to their baseline concentrations in
a cohort of US football and hockey college athletes. However, prior studies have found that plasma
Nf-L concentrations at 1, 12, 36, and 144 hours after SRC could discriminate players with more than 10
days before RTS from those with 10 days or less before RTS in professional hockey players.8
Disparities in these findings might result from cohort differences in age and previous concussion
history. College-aged cohorts tend to be younger than professional athletes, which might result in
differential responses to trauma. Moreover, professional players may have been exposed to a larger
number of concussions and repetitive head impact exposures during the course of the season or their
careers compared with college athletes. Accordingly, Nf-L has been linked to repetitive concussive
impacts in contact-sport athletes.7,25,28 Indeed, our laboratory has previously observed that plasma
Nf-L concentrations were elevated in military personnel who had sustained repetitive TBIs compared
with those with 1 or 2 TBIs, but no differences were observed between control and TBI groups.29
Despite recent progress in SRCs, the prognostic value of Nf-L is yet to be fully ascertained. We
hypothesize that Nf-L has limited sensitivity in milder cases of SRC and may become more evident as
the number of SRCs sustained increases. Indeed, in this cohort, most participants (55.9%) reported
having no prior concussions. Future studies should further evaluate the potential of Nf-L in mTBI
patients, and it may be worthwhile to monitor Nf-L longitudinally across athletic careers.
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Limitations
Although this article uses data from, to our knowledge, the largest prospective sample of SRC in
athletes to date, there are a number of limitations to note. Specifically, from the larger CARE
Consortium pool of participants, our sample included a relatively small number of athletes who
sustained an SRC with complete data on RTS and blood biomarkers. As such, the findings may not
generalize to the wider collegiate community. However, the CARE Consortium study is ongoing, and
we anticipate that we will be able to continue to gather a more representative sample to replicate
and extend this work. Furthermore, because of the nature of the injury itself (occurring at any time of
day), alongside participant schedules, we were unable to standardize the time of biomarker
collection at each of the periods. Therefore, we were unable to rule out the influence of circadian
timing on variations in biomarkers. There is no research to suggest that plasma concentrations of
total tau, GFAP, or Nf-L show a diurnal pattern in humans; however, a relationship between sleep-
wake disturbances and tau accumulation has been reported.30,31 Future studies, which account for
sleep-wake patterns pre-injury and postinjury as well as before blood sampling present an intriguing
and growing line of investigation. We were also unable to determine whether the changes in the
biomarkers observed were owing to central or peripheral mechanisms. Future work will determine
the relationship between the selected biomarkers and more direct measures of neuropathology (ie,
neuroimaging). RTS is an outcome affected by several extraneous variables, including symptom
recovery time and clinical management practices at each institution. In line with this, it was noted
that the group that took less than 14 days to RTS had significantly more years of sports participation
than those who took 14 or more days to RTS. One rationale for this difference is that more years of
sports participation results in players having a better understanding of when they are fit to RTS.
However, the number of prior concussions did not differ. As such, it may also be that players with
more years of sporting participation feel more compelled or more pressure to RTS earlier. Further
research into the individual psychological determinants of RTS may be needed to elucidate these
findings further. This investigation is a first step in the process of identifying biomarkers that are
associated with duration of recovery; however, it is evident that the need for continued longitudinal
tracking of these athletes, including blood biomarkers alongside clinical outcomes, remains.
Conclusions
Biomarkers that are associated with duration of recovery after SRC are needed to improve the clinical
management of concussion. In this study, higher total tau concentrations at 24 to 48 hours postinjury
and at the time of symptom resolution and lower GFAP concentrations at the postinjury period were
associated with protracted RTS (ie, 14 days) in male and female collegiate athletes following SRC.
Although preliminary, the current results highlight the potential role of biomarkers in tracking
neuronal recovery, which may be associated with duration of RTS. Continued longitudinal tracking of
this cohort is underway. We will continue to explore this association between biomarkers and their
ability to track recovery in male and female athletes following SRC.
ARTICLE INFORMATION
Accepted for Publication: May 20, 2020.
Published: August 27, 2020. doi:10.1001/jamanetworkopen.2020.13191
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Pattinson
CL et al. JAMA Network Open.
Corresponding Author: Jessica Gill, PhD, National Institute of Nursing Research, National Institutes of Health,
Bldg 10-CRC, 10 Center Dr, Bethesda, MD 20814 (gillj@mail.nih.gov).
Author Affiliations: National Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland
(Pattinson, Guedes, Lai, Devoto, Gill); Institute for Social Science Research, University of Queensland, Brisbane
JAMA Network Open | Physical Medicine and Rehabilitation Plasma Biomarker Concentrations and Return to Sport Following Sport-Related Concussion
JAMA Network Open. 2020;3(8):e2013191. doi:10.1001/jamanetworkopen.2020.13191 (Reprinted) August 27, 2020 8/11
Downloaded From: https://jamanetwork.com/ on 04/30/2021
(Pattinson); Department of Neurosurgery, Medical College of Wisconsin, Milwaukee (Meier, Huber, Nelson,
McCrea); Center for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health
Sciences, Bethesda, Maryland (Haight); The Henry M. Jackson Foundation for the Advancement of Military
Medicine, Bethesda, Maryland (Haight); Michigan Concussion Center, University of Michigan, Ann Arbor (Broglio);
Department of Psychiatry, Indiana University School of Medicine, Indianapolis (McAllister); Department of
Neurosurgery and Pediatrics, UCLA Steve Tisch BrainSPORT Program, University of California, Los Angeles (Giza);
Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington
(Harezlak); Keller Army Community Hospital, West Point, New York (Cameron); United States Air Force Academy,
Colorado (McGinty, Jackson); Matthew Gfeller Sport-Related Traumatic Brain Injury Research Center, Department
of Exercise and Sport Science, University of North Carolina, Chapel Hill (Guskiewicz, Mihalik); Department of
Orthopedics and Sports Medicine, School of Medicine and Public Health, University of Wisconsin–Madison
(Brooks); Department of Biomedical Engineering, Virginia Tech, Blacksburg (Duma, Rowson); Department of
Physical Medicine and Rehabilitation, Uniformed Services University of the Health Sciences, Bethesda, Maryland
(Pasquina).
Author Contributions: Drs Pattinson and Gill had full access to all of the data in the study and take responsibility
for the integrity of the data and the accuracy of the data analysis. Drs McCrea and Gill contributed equally as senior
authors on this manuscript.
Concept and design: Meier, Broglio, McAllister, Giza, Harezlak, Cameron, Guskiewicz, Pasquina, McCrea, Gill.
Acquisition, analysis, or interpretation of data: Pattinson, Meier, Guedes, Lai, Devoto, Haight, Broglio, Giza, Huber,
Harezlak, Cameron, McGinty, Jackson, Guskiewicz, Mihalik, Brooks, Duma, Rowson, Nelson, Pasquina,
McCrea, Gill.
Drafting of the manuscript: Pattinson, Guedes, Devoto, McCrea, Gill.
Critical revision of the manuscript for important intellectual content: Pattinson, Meier, Lai, Haight, Broglio,
McAllister, Giza, Huber, Harezlak, Cameron, McGinty, Jackson, Guskiewicz, Mihalik, Brooks, Duma, Rowson,
Nelson, Pasquina, McCrea, Gill.
Statistical analysis: Pattinson, Guedes, Lai, Devoto, Haight, Harezlak, McCrea, Gill.
Obtained funding: Broglio, McAllister, Guskiewicz, Rowson, Pasquina, McCrea, Gill.
Administrative, technical, or material support: Guedes, Lai, Broglio, McAllister, Giza, Huber, Guskiewicz, Mihalik,
Nelson, Pasquina, McCrea, Gill.
Supervision: Meier, Guedes, Lai, Broglio, Giza, Cameron, Brooks, Duma, Pasquina, Gill.
Conflict of Interest Disclosures: Dr Broglio reported receiving travel expenses from the National Collegiate
Athletic Association (NCAA), serving as an unpaid consultant for US Soccer and US Cycling, participating in medico-
legal litigation, receiving speaker honorarium and travel reimbursements for talks given, and serving on the
University of Calgary SHRed Concussions external advisory board. Dr Giza reported receiving grants from the
University of California Los Angeles Steve Tisch BrainSPORT Program, the University of California Los Angeles
Easton Clinic for Brain Health, grants from the University of California Los Angeles Brain Injury Research Center, the
National Institute of Neurological Disorders and Stroke Small Business Innovative Research, and the National
Institute of Neurological Disorders and Stroke outside the submitted work; serving as a clinical consultant for the
National Basketball Association, National Football League–Neurological Care Program, and National Hockey
League Players Association; serving on the advisory board of Highmark Interactive (2018-2019), Novartis
Pharmaceutical (2019), Major League Soccer, the National Basketball Association, and US Soccer Federation;
participating in medico-legal litigation; owning stock in Highmark Interactive (2018); and receiving book royalties
from Blackwell/Wiley Publishing. Dr Cameron reported receiving grants from the National Institutes of Health
during the conduct of the study and serving on the board of directors of the NATA Foundation. Dr Guskiewicz
reported serving on the scientific advisory board of the NCAA outside the submitted work. Dr Nelson reported
receiving grants from National Institutes of Health, the US Centers for Disease Control and Prevention, MCW
Advancing a Healthier Wisconsin Endowment, and the Department of Defense and receiving personal fees from
the Department of Energy outside the submitted work. Dr Pasquina reported grants from Department of Defense
during the conduct of the study. Dr McCrea reported receiving grants from the National Institutes of Health, the
US Centers for Disease Control and Prevention, the National Football League, and the US Department of Veterans
Affairs outside the submitted work. No other disclosures were reported.
Funding/Support: This publication was made possible with support from the Grand Alliance Concussion
Assessment, Research, and Education (CARE) Consortium, funded, in part by the NCAA and the Department of
Defense. The US Army Medical Research Acquisition Activity, 820 Chandler St, Ft Detrick, MD 21702, is the
awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of
Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under award No.
W81XWH-14-2-0151.
JAMA Network Open | Physical Medicine and Rehabilitation Plasma Biomarker Concentrations and Return to Sport Following Sport-Related Concussion
JAMA Network Open. 2020;3(8):e2013191. doi:10.1001/jamanetworkopen.2020.13191 (Reprinted) August 27, 2020 9/11
Downloaded From: https://jamanetwork.com/ on 04/30/2021
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection,
management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and
decision to submit the manuscript for publication.
Disclaimer: Opinions, interpretations, conclusions and recommendations are those of the author and are not
necessarily endorsed by the US Department of Defense.
CARE Consortium Investigators: Tatiana Foroud, PhD, Barry Katz, PhD, and Andrew Saykin, PhD (Indiana
University School of Medicine, Indianapolis); Darren E. Campbell, MD, Gerald McGinty, DPT, and Jonathan Jackson,
MD (United States Air Force Academy, Colorado); Megan Houston, PhD, Kenneth Cameron, PhD, and Steven
Svoboda, MD (United States Military Academy, West Point, New York); Joshua Goldman, MD, and Jon DiFiori, MD
(University of California, Los Angeles, Los Angeles, California). All authors fulfill the criteria of authorship; there is
no one else who fulfills the criteria that has been excluded as an author.
Additional Contributions: The authors would also like to thank Jody Harland, BA, MS, Janetta Matesan, BS, Larry
Riggen MS, and Michael Menser, MS (Indiana University); Ashley Rettmann, BS, and Nicole L’Heureux BSN, MBA,
(University of Michigan); Melissa Koschnitzke, MA, CCRC (Medical College of Wisconsin); Michael Jarrett, MBA,
Vibeke Brinck, MS, and Bianca Byrne, BA (Quesgen); Melissa Niceley Baker, BA, and Sara Dalton, MEd (Datalys
Center for Sports Injury Research and Prevention); and the research and medical staff at each of the CARE
participation sites. These contributors received support from research funding to their institution for time
dedicated to this study.
REFERENCES
1. Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief
overview. J Head Trauma Rehabil. 2006;21(5):375-378. doi:10.1097/00001199-200609000-00001
2. McKee AC, Cantu RC, Nowinski CJ, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy
after repetitive head injury. J Neuropathol Exp Neurol. 2009;68(7):709-735. doi:10.1097/NEN.
0b013e3181a9d503
3. McCrea M, Broglio S, McAllister T, et al; CARE Consortium Investigators. Return to play and risk of repeat
concussion in collegiate football players: comparative analysis from the NCAA Concussion Study (1999-2001) and
CARE Consortium (2014-2017). Br J Sports Med. 2020;54(2):102-109. doi:10.1136/bjsports-2019-100579
4. Manley G, Gardner AJ, Schneider KJ, et al. A systematic review of potential long-term effects of sport-related
concussion. Br J Sports Med. 2017;51(12):969-977. doi:10.1136/bjsports-2017-097791
5. Slobounov S, Slobounov E, Sebastianelli W, Cao C, Newell K. Differential rate of recovery in athletes after first
and second concussion episodes. Neurosurgery. 2007;61(2):338-344. doi:10.1227/01.NEU.0000280001.
03578.FF
6. Gill J, Merchant-Borna K, Jeromin A, Livingston W, Bazarian J. Acute plasma tau relates to prolonged return to
play after concussion. Neurology. 2017;88(6):595-602. doi:10.1212/WNL.0000000000003587
7. Shahim P, Tegner Y, Wilson DH, et al. Blood biomarkers for brain injury in concussed professional ice hockey
players. JAMA Neurol. 2014;71(6):684-692. doi:10.1001/jamaneurol.2014.367
8. Shahim P, Tegner Y, Marklund N, Blennow K, Zetterberg H. Neurofilament light and tau as blood biomarkers for
sports-related concussion. Neurology. 2018;90(20):e1780-e1788. doi:10.1212/WNL.0000000000005518
9. Wallace C, Zetterberg H, Blennow K, van Donkelaar P. No change in plasma tau and serum neurofilament light
concentrations in adolescent athletes following sport-related concussion. PLoS One. 2018;13(10):e0206466. doi:
10.1371/journal.pone.0206466
10. Shahim P, Tegner Y, Marklund N, et al. Astroglial activation and altered amyloid metabolism in human
repetitive concussion. Neurology. 2017;88(15):1400-1407. doi:10.1212/WNL.0000000000003816
11. NCAA. Interassociation consensus: diagnosis and management of sport-related concussion best practices.
Accessed July 19, 2019. http://www.ncaa.org/sites/default/files/SSI_ConcussionBestPractices_20170616.pdf
12. McAllister TW, Broglio SP, McCrea MA, et al. Evolution and findings of the CARE Consortium: a pivot to studying
cumulative and persistent effects of concussion and repetitive head impact exposure. Paper presented at: Military
Health System Research Symposium; August 20-23, 2018; Kissimmee, Florida. Accessed July 28, 2020. https://
docplayer.net/98038631-Mhsrs-symposium-guide-august-20-23-2018-gaylord-palms-resort-convention-
center-kissimmee-fl-military-health-system-research-symposium.html
13. Broglio SP, McCrea M, McAllister T, et al; CARE Consortium Investigators. A national study on the effects of
concussion in collegiate athletes and us military service academy members: the NCAA-DoD Concussion
Assessment, Research and Education (CARE) Consortium structure and methods. Sports Med. 2017;47(7):
1437-1451. doi:10.1007/s40279-017-0707-1
JAMA Network Open | Physical Medicine and Rehabilitation Plasma Biomarker Concentrations and Return to Sport Following Sport-Related Concussion
JAMA Network Open. 2020;3(8):e2013191. doi:10.1001/jamanetworkopen.2020.13191 (Reprinted) August 27, 2020 10/11
Downloaded From: https://jamanetwork.com/ on 04/30/2021
14. Carney N, Ghajar J, Jagoda A, et al. Concussion guidelines step 1: systematic review of prevalent indicators.
Neurosurgery. 2014;75(suppl 1):S3-S15. doi:10.1227/NEU.0000000000000433
15. Ljungqvist J, Zetterberg H, Mitsis M, Blennow K, Skoglund T. Serum neurofilament light protein as a marker for
diffuse axonal injury: results from a case series study. J Neurotrauma. 2017;34(5):1124-1127. doi:10.1089/neu.
2016.4496
16. Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5
(9):1315-1316. doi:10.1097/JTO.0b013e3181ec173d
17. Iliff JJ, Chen MJ, Plog BA, et al. Impairment of glymphatic pathway function promotes tau pathology after
traumatic brain injury. J Neurosci. 2014;34(49):16180-16193. doi:10.1523/JNEUROSCI.3020-14.2014
18. Albayram O, Kondo A, Mannix R, et al. Cis P-tau is induced in clinical and preclinical brain injury and contributes
to post-injury sequelae. Nat Commun. 2017;8(1):1000. doi:10.1038/s41467-017-01068-4
19. Castellani RJ, Perry G. Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges. J Alzheimers
Dis. 2019;67(2):447-467. doi:10.3233/JAD-180721
20. Gill J, Latour L, Diaz-Arrastia R, et al. Glial fibrillary acidic protein elevations relate to neuroimaging
abnormalities after mild TBI. Neurology. 2018;91(15):e1385-e1389. doi:10.1212/WNL.0000000000006321
21. Asken BM, Bauer RM, DeKosky ST, et al. Concussion BASICS III: serum biomarker changes following sport-
related concussion. Neurology. 2018;91(23):e2133-e2143. doi:10.1212/WNL.0000000000006617
22. McCrea M, Huber DL, Gill JM, et al. Blood biomarkers in acute sport-related concussion: findings from the
NCAA-DoD CARE Consortium. Poster presented at: Military Health System Research Symposium. August 21, 2019.
Kissimmee, Florida. Accessed July 28, 2020. https://www.mhsrs.net/wp-content/uploads/2019/07/MHSRS-2019-
Poster-Session-2-Information.pdf
23. Nylén K, Öst M, Csajbok LZ, et al. Increased serum-GFAP in patients with severe traumatic brain injury is
related to outcome. J Neurol Sci. 2006;240(1-2):85-91. doi:10.1016/j.jns.2005.09.007
24. Posti JP, Takala RSK, Runtti H, et al. The levels of glial fibrillary acidic protein and ubiquitin c-terminal
hydrolase-L1 during the first week after a traumatic brain injury: correlations with clinical and imaging findings.
Neurosurgery. 2016;79(3):456-464. doi:10.1227/NEU.0000000000001226
25. Shahim P, Tegner Y, Gustafsson B, et al. Neurochemical aftermath of repetitive mild traumatic brain injury.
JAMA Neurol. 2016;73(11):1308-1315. doi:10.1001/jamaneurol.2016.2038
26. Bernick C, Zetterberg H, Shan G, Banks S, Blennow K. Longitudinal performance of plasma neurofilament light
and tau in professional fighters: the Professional Fighters Brain Health Study. J Neurotrauma. 2018;35(20):
2351-2356. doi:10.1089/neu.2017.5553
27. Meeter LH, Dopper EG, Jiskoot LC, et al. Neurofilament light chain: a biomarker for genetic frontotemporal
dementia. Ann Clin Transl Neurol. 2016;3(8):623-636. doi:10.1002/acn3.325
28. Oliver JM, Jones MT, Kirk KM, et al. Serum neurofilament light in American football athletes over the course of
a season. J Neurotrauma. 2016;33(19):1784-1789. doi:10.1089/neu.2015.4295
29. Pattinson CL, Shahim P, Taylor P, et al. Elevated tau in military personnel relates to chronic symptoms
following traumatic brain injury. J Head Trauma Rehabil. 2020;35(1):66-73. doi:10.1097/htr.
0000000000000485
30. Motamedi V, Kanefsky R, Matsangas P, et al. Elevated tau and interleukin-6 concentrations in adults with
obstructive sleep apnea. Sleep Med. 2018;43:71-76. doi:10.1016/j.sleep.2017.11.1121
31. Holth JK, Fritschi SK, Wang C, et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF
tau in humans. Science. 2019;363(6429):880-884. doi:10.1126/science.aav2546
SUPPLEMENT.
eTable. Demographic Characteristics of Participants With and Without Missing Biomarker Data at the Postinjury
Period
JAMA Network Open | Physical Medicine and Rehabilitation Plasma Biomarker Concentrations and Return to Sport Following Sport-Related Concussion
JAMA Network Open. 2020;3(8):e2013191. doi:10.1001/jamanetworkopen.2020.13191 (Reprinted) August 27, 2020 11/11
Downloaded From: https://jamanetwork.com/ on 04/30/2021
